Vishuo Biomedical is a Singapore-based healthcare company dedicated to establishing precision medicine for prognosis, diagnosis and treatment of various life-threatening diseases. We deliver genomic data analysis and interpretation to research institutes, healthcare providers and pharmaceutical companies.
Since 2012, our products and services have been dominating the biomedical market in China. The iCMDB platform has also been applied to multiple first-tier hospitals in Singapore, China, Thailand and USA. Our analysis workflow has been further reinforced through establishing sequencing facilities in these collaborating hospitals. iCMDB is certified by ISO13485:2003, and classified as a Class A medical device by Singapore Health Sciences Authority (HSA).
To bridge biomedical big data and personalized medical care to improve patient outcome and quality of life.
PRECISION: guarantee the credibility of our analysis
INTEGRITY: protect confidential information
ACCOUNTABILITY: responsibility to our stakeholders